Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus

BACKGROUND: Anti-Embolism (AE) devices therapy is an additional antithrombotic treatment that is effective in many venous diseases, but the correlations between this medical compression therapy and cardiovascular arterial disease or comorbid diabetes mellitus (DM) are still controversial. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaxuan, Zhang, Luming, Xu, Mengyuan, Yuan, Shiqi, Ye, Yan, Huang, Tao, Yin, Haiyan, Lyu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343674/
https://www.ncbi.nlm.nih.gov/pubmed/35928930
http://dx.doi.org/10.3389/fcvm.2022.948924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343674/
https://www.ncbi.nlm.nih.gov/pubmed/35928930
http://dx.doi.org/10.3389/fcvm.2022.948924

Ejemplares similares